Novel triazine compounds for treatment of cancer

Details for Australian Patent Application No. 2008270269 (hide)

Owner TriN Pharma GmbH

Inventors Forster, Heinz; Reiter, Rudolf; Kalbe, Jochen

Agent Freehills

Pub. Number AU-A-2008270269

PCT Pub. Number WO2009/004060

Priority 07111716.2 04.07.07 EP

Filing date 3 July 2008

Wipo publication date 8 January 2009

International Classifications

C07C 245/24 (2006.01) Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond

A61K 31/655 (2006.01) - Azo (NN), diazo (N), azoxy (NON or N(O)N), azido (N) or diazoamino (NNN) compounds

A61P 35/04 (2006.01) Antineoplastic agents

C07C 309/15 (2006.01) Sulfonic acids

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/004060 Priority application(s): WO2009/004060

4 February 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Novel triazene compounds for the treatment of cancer

18 August 2011 Assignment before Grant

  TriN Pharma GmbH The application has been assigned to TriN Therapeutics GmbH

12 April 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Aug 2011 and 6 and 22 March 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008270274-Providing improved immunoglobulin sequences by mutating CDR and/or FR positions

2008270264-Apparatus and method for operating an elevator